Furosemide Stress Test in Acute Kidney Injury

Purpose and Clinical Utility

• The furosemide stress test (FST) is a functional biomarker used to predict progression to severe AKI (stage 3) and the need for renal replacement therapy (RRT) in patients with early-stage AKI, as recommended by Kidney International 1.
• The American College of Physicians and other medical societies suggest that the FST should be considered for risk stratification in critically ill patients with stage 1 or 2 AKI, though it was not included in the original 2012 KDIGO guidelines and requires careful standardization 1.

Key Clinical Applications

• The FST serves to predict progression to stage 3 AKI in patients with early-stage disease, with area under the curve (AUC) values of 0.87-0.93 for this outcome, as reported by JAMA network open 2.
• The FST can identify patients who will require RRT, with AUC values of 0.76-0.96 for predicting dialysis need, according to JAMA network open 2.
• The FST can predict successful discontinuation of continuous RRT in patients with established AKI (AUC = 0.84), as stated by JAMA network open 2.

Critical Contraindications and Warnings

• The International Club of Ascites guidelines recommend that furosemide should not be used in patients with cirrhosis and new-onset AKI, and should be withdrawn immediately 3, 4.
• The FST should not be performed in hemodynamically unstable patients, as it may precipitate volume depletion, hypotension, and further renal hypoperfusion, as warned by Praxis Medical Insights 3, 4.
• Each nephrotoxic medication increases AKI odds by 53%, and furosemide is associated with worsening renal function, as reported by Praxis Medical Insights 3, 4.

Monitoring Requirements During and After FST

• Electrolytes should be monitored every 12-24 hours during IV diuretic therapy, and daily renal function assessment (serum creatinine, BUN) should be performed, as recommended by Praxis Medical Insights 3, 4.
• The FST should only be performed after ensuring adequate intravascular volume, and volume status should be reassessed after the test, as suggested by Intensive Care Medicine 5.

Integration with Clinical Decision-Making

• For patients with urine output <200 mL in first 2 hours, anticipate progression to stage 3 AKI and prepare for potential RRT, and intensify monitoring of renal function and fluid balance, as recommended by Praxis Medical Insights 3.
• Consider early nephrology consultation for RRT planning in patients with high-risk FST results, as suggested by JAMA network open 2.
• The FST can predict successful CRRT cessation with AUC of 0.84, and consider performing FST before attempting CRRT discontinuation in non-septic patients with AKI, as reported by JAMA network open 2.

Furosemide Stress Test for Acute Kidney Injury

Introduction to Furosemide Stress Test

• The Acute Disease Quality Initiative (ADQI) consensus framework recognizes the Furosemide Stress Test (FST) as a tool to evaluate renal reserve in patients with acute kidney disease, with a focus on tubular stress testing 6, 7

Relationship to Renal Reserve Assessment

• The FST represents one method of tubular stress testing to assess renal reserve, which is particularly relevant for patients recovering from AKI who may have lost functional reserve despite normalized creatinine, as noted by the ADQI consensus framework 6, 7

Furosemide Stress Test in Acute Kidney Injury Decision‑Making

Role of the FST in Risk Stratification

• The Furosemide Stress Test can be employed to stratify the risk of progression of acute kidney injury (AKI) and to predict the need for renal replacement therapy (RRT), but it must not be used as the sole criterion to initiate RRT in euvolemic patients without an absolute indication. 8

KDIGO 2020 Guideline Recommendations

Integration of the FST

• KDIGO 2020 recommends that a standardized FST may be considered in AKI to quantify the probability of progression; the result should be integrated with all other available clinical information when making RRT decisions. 8

Use of Biomarkers

• KDIGO advises that biomarkers alone are not recommended for deciding to start RRT. 8

Indications for Initiating RRT

• KDIGO proposes that initiation of RRT should be considered when metabolic and volume demands exceed the residual renal capacity of the patient. 8

Comprehensive Clinical Decision‑Making

• Although the FST helps quantify residual renal capacity, the final decision to start RRT must incorporate the overall clinical context, including the AKI trajectory, comorbid conditions, and the patient’s care goals. 8

Furosemide Stress Test: Evidence‑Based Indications and Contraindications

Functional Assessment Role

• The Furosemide Stress Test evaluates tubular function and reserve rather than glomerular filtration, providing a functional assessment of kidney tubular capacity when plasma biomarkers (e.g., NGAL) indicate renal stress. This interpretation should be integrated with overall renal physiology. 9

Contraindications

• In patients with cirrhosis who develop new‑onset acute kidney injury, the FST should not be performed; furosemide must be withdrawn immediately to avoid worsening renal function. [10][11]

Standardization and Quality Control of the Furosemide Stress Test (FST)

Institutional Protocol Development

• Institutions should create standardized protocols that define the exact furosemide dosing (e.g., 1 mg/kg for diuretic‑naïve patients, 1.5 mg/kg for recent diuretic exposure), timing of administration, and interpretation criteria (e.g., urine output thresholds) to ensure consistent test performance across providers. 12

Staff Training and Technique Standardization

• All personnel involved in the FST must receive training on proper urine collection, hourly measurement techniques, and documentation procedures to minimize variability and measurement error. 12

Quality Assurance and Performance Monitoring

• Implement ongoing quality‑assurance measures—such as periodic audits of dosing accuracy, timing adherence, and outcome tracking—to verify that the test is performed reliably and that interpretation aligns with established thresholds. 12